A meta-analysis assessing IVI safety with anti-VEGF agents in office-based and operating room settings revealed that ocular perioperative complications, including posterior vitreous detachment, iatrogenic/traumatic cataract, retinal detachment, and retinal tears, mainly resulted from improper injection techniques. The gene discussed is VEGFA; the disease is retinal detachment.